Search alternatives:
"novell" » "novels", "lovell", "novellen"
"novelle" » "novelse", "lovelle", "novellene"

1
Published 2013
Canadian Agency for Drugs and Technologies in Health
..., are not well-established. The emergence of novel oral and injectable agents necessitates consideration...

2
Published 2013
Canadian Agency for Drugs and Technologies in Health
..., are not well-established. The emergence of novel oral and injectable agents necessitates consideration...

3
Published 2017
Canadian Agency for Drugs and Technologies in Health
... receptor agonist. Farnesoid receptors are a novel pharmacological target, and stimulation...

4
Published 2017
Canadian Agency for Drugs and Technologies in Health
... receptor agonist. Farnesoid receptors are a novel pharmacological target, and stimulation...

5
Published 2013
Canadian Agency for Drugs and Technologies in Health
... or hypersensitivity reactions, and novel anti-proliferative agents....

6
Published 2013
Canadian Agency for Drugs and Technologies in Health
... or hypersensitivity reactions, and novel anti-proliferative agents....

7
Published 2016
Canadian Agency for Drugs and Technologies in Health
... recently developed antimicrobia l therapy is the fixed-dose combination of ceftolozane (a novel...

8
Published 2016
Canadian Agency for Drugs and Technologies in Health
... recently developed antimicrobia l therapy is the fixed-dose combination of ceftolozane (a novel...

9
Published 2014
Canadian Agency for Drugs and Technologies in Health
... sampling (CVS). Recently, a novel prenatal testing method has become available. This method, known as non...

10
Published 2014
Canadian Agency for Drugs and Technologies in Health
... sampling (CVS). Recently, a novel prenatal testing method has become available. This method, known as non...

11
Published 2014
Canadian Agency for Drugs and Technologies in Health
... sofosbuvir employs a novel mechanism of action targeting an HCV polymerase and is approved for the treatment...

12
Published 2014
Canadian Agency for Drugs and Technologies in Health
... sofosbuvir employs a novel mechanism of action targeting an HCV polymerase and is approved for the treatment...

13
Published 2014
Canadian Agency for Drugs and Technologies in Health
..., seizures, weight loss, peripheral neuropathy, and bone marrow suppression. A number of novel DAA regimens...

14
Published 2015
Canadian Agency for Drugs and Technologies in Health

15
Published 2015
Canadian Agency for Drugs and Technologies in Health

16
Published 2014
Canadian Agency for Drugs and Technologies in Health
..., seizures, weight loss, peripheral neuropathy, and bone marrow suppression. A number of novel DAA regimens...

17
Published 2014
Canadian Agency for Drugs and Technologies in Health